|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,150.00 TWD | -2.54% |
|
-12.88% | +171.42% |
| 07-22 | PharmaEssentia Seeks Macau Nod to Expand Besremi Use for Rare Blood Cancer | MT |
| 07-09 | PharmaEssentia Swings to Profit in May as Revenue Balloons 108% | MT |
| Market Cap | 486B 15B 13.14B 12.2B 11.21B 21.12B 1,447B 21.43B 145B 56.88B 708B 56.3B 55.09B 2,446B | P/E 2026 * |
45.3x | P/E 2027 * | 32.9x |
|---|---|---|---|---|---|
| Enterprise Value | 460B 14.18B 12.42B 11.53B 10.6B 19.97B 1,368B 20.27B 137B 53.78B 670B 53.23B 52.08B 2,313B | EV / Sales 2026 * |
18.3x | EV / Sales 2027 * | 13.1x |
| Free-Float |
75.37% | Yield 2026 * |
0.08% | Yield 2027 * | 0.12% |
| 1 day | -2.54% | ||
| 1 week | -12.88% | ||
| Current month | -4.80% | ||
| 1 month | +16.50% | ||
| 3 months | +97.17% | ||
| 6 months | +128.61% | ||
| Current year | +171.42% |
| 1 week | 1,125 |  | 1,260 |
| 1 month | 978.11 | | 1,415.34 |
| Current year | 423.7 | | 1,415.34 |
| 1 year | 395.61 | | 1,415.34 |
| 3 years | 222.58 | | 1,415.34 |
| 5 years | 56.05 | | 1,415.34 |
| 10 years | 43.54 | | 1,415.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
CEO | Chief Executive Officer | - | 01/01/2003 |
Hsueh Ling Chang
DFI | Director of Finance/CFO | - | 14/10/2015 |
Albert Qin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ching Liu Chan
CHM | Chairman | - | 01/09/2003 |
Cheng Ku Huang
BRD | Director/Board Member | - | - |
Chao Ho Chen
BRD | Director/Board Member | - | 30/06/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.54% | -12.88% | +168.62% | +289.45% | 15B | |
| +1.23% | -3.08% | +53.96% | +87.98% | 55.27B | |
| +4.91% | +6.00% | +62.78% | +66.05% | 54.15B | |
| -0.05% | -0.22% | +3.65% | +424.05% | 23.11B | |
| -0.42% | +0.19% | -19.96% | -14.30% | 23.22B | |
| +1.03% | -0.76% | +40.14% | -3.59% | 20.33B | |
| -0.37% | +0.71% | +31.36% | -29.32% | 17.91B | |
| +0.87% | -2.80% | +37.96% | +600.00% | 15.76B | |
| +0.99% | -0.43% | +22.11% | +178.73% | 13.82B | |
| +1.28% | +0.27% | +78.32% | +165.96% | 12.4B | |
| Average | +0.68% | -0.56% | +47.90% | +176.50% | 25.1B | |
| Weighted average by Cap. | +1.35% | +1.02% | +46.96% | +141.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 25.07B 773M 677M 629M 578M 1.09B 74.58B 1.1B 7.49B 2.93B 36.49B 2.9B 2.84B 126B | 34.57B 1.07B 934M 867M 797M 1.5B 103B 1.52B 10.33B 4.04B 50.32B 4B 3.91B 174B |
| Net income | 10.85B 335M 293M 272M 250M 471M 32.29B 478M 3.24B 1.27B 15.8B 1.26B 1.23B 54.59B | 14.97B 462M 404M 375M 345M 650M 44.54B 660M 4.47B 1.75B 21.79B 1.73B 1.7B 75.29B |
| Net Debt | -26.52B -818M -717M -665M -611M -1.15B -78.91B -1.17B -7.92B -3.1B -38.61B -3.07B -3B -133B | -34.73B -1.07B -938M -871M -800M -1.51B -103B -1.53B -10.38B -4.06B -50.56B -4.02B -3.93B -175B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/07/26 | NT$1,150.00 | -2.54% | 2,923,089 |
| 22/07/26 | NT$1,180.00 | +0.43% | 2,030,357 |
| 21/07/26 | NT$1,175.00 | 0.00% | 2,044,851 |
| 20/07/26 | NT$1,175.00 | -1.67% | 2,926,691 |
| 17/07/26 | NT$1,195.00 | -5.16% | 3,377,763 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6446 Stock
Select your edition
All financial news and data tailored to specific country editions
